JORDAN WALLACE: Open Payments
NPI 1063291789 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 12 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| Incyte Corporation | 1 | $27 |
| Exelixis Inc. | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Pharmacosmos Therapeutics Inc. | 1 | $15 |
Products named: KEYTRUDA, Enhertu, NINLARO, JAKAFI, FRUZAQLA, CABOMETYX, Onivyde, VIVIMUSTA.
Industry payments across AR — which companies pay providers there.
